FBTDX Mutual Fund (Franklin Biotechnology Discovery Fund Class C) is managed by Franklin Templeton Investments (US) with $46.6M in net assets. FBTDX expense ratio is 1.77%, holding 94 positions across sectors including Health Care, Unknown, Financials. Inception date: 2014-03-04.

FBTDX performance shows a YTD return of 3.95%. The 1-year return is 54.11% and the 5-year return is 7.80%. FBTDX dividend yield stands at 1.72%, paid annually.

FBTDX top holdings include Gilead Sciences Inc (5.6%), Nvaesrtex Pharmaceuticals Inc (4.6%), Amgen Inc. (4.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.1%), Regeneron Pharmaceuticals, Inc. (4.1%). View all FBTDX holdings, sector breakdown, or dividend history.

FBTDX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTDX alternatives are available via the screener, along with tax-loss harvesting opportunities.